Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. __)*
Under the Securities Exchange Act of 1934
AYTU BIOSCIENCE, INC.
(Name of Issuer)
Common Stock, $0.001 Par Value
(Title of Class of Securities)
054754700
(CUSIP Number)
April 10, 2020
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
o |
Rule 13d-1(b) |
|
|
x |
Rule 13d-1(c) |
|
|
o |
Rule 13d-1(d) |
|
* |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
CUSIP No. 054754700
|
|
|
| |||
|
|
1. |
Name of Reporting Person | |||
|
| |||||
|
|
2. |
Check the Appropriate Box if a Member of a Group | |||
|
|
|
|
(a) o | ||
|
|
|
N/A |
(b) o | ||
|
| |||||
|
|
3. |
SEC Use Only | |||
|
| |||||
|
|
4. |
Citizenship or Place of Organization | |||
|
|
|
| |||
|
Number of |
5. |
Sole Voting Power | |||
|
| |||||
|
6. |
Shared Voting Power | ||||
|
| |||||
|
7. |
Sole Dispositive Power | ||||
|
| |||||
|
8. |
Shared Dispositive Power | ||||
|
| |||||
|
|
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person | |||
|
| |||||
|
|
10. |
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares | |||
|
| |||||
|
|
11. |
Percent of Class Represented by Amount in Row (9) | |||
|
| |||||
|
|
12. |
Type of Reporting Person | |||
CUSIP No. 054754700
Item 1(a) Name of Issuer
Aytu Bioscience, Inc. (the “Issuer”)
Item 1(b) Address of Issuer’s Principal Executive Offices
373 Inverness Parkway, Suite 206, Englewood, Colorado 80112
Item 2(a) Name of Person Filing
Cerecor Inc. (the “Reporting Person”)
Item 2(b) Address of Principal Business Office, or if none, Residence
540 Gaither Road, Suite 400, Rockville, Maryland 20850
Item 2(c) Citizenship
The Reporting Person is a Delaware company.
Item 2(d) Title of Class of Securities
Common Stock, $0.001 par value per share
Item 2(e) CUSIP Number
054754700
Item 3. Filing pursuant to Rules 13d-1(b) or 13d-2(b) or (c)
Not Applicable
Item 4. Ownership
On April 10, 2020 the Reporting Person converted 9,805,845 shares of the Issuer’s convertible preferred stock into 9,805,845 shares of the Issuer’s common stock, and became a 8.32% stockholder in the Issuer. As of the date of this filing, the Reporting Person does not own any shares of the Issuer’s common stock and therefore has 0% holdings in the Issuer.
(a) Amount beneficially owned:
0
(b) Percent of class:
0%
(c) Number of shares as to which such person has:
The Reporting Person has sole voting and dispositive power of 0 shares.
CUSIP No. 054754700
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. X
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not Applicable
Item 8. Identification and Classification of Members of the Group
Not Applicable
Item 9. Notice of Dissolution of Group
Not Applicable
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
CUSIP No. 054754700
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: April 27, 2020
|
|
CERECOR INC. | |
|
|
| |
|
|
By: |
/s/ Christopher Sullivan |
|
|
Name: |
Christopher Sullivan |
|
|
Title: |
Interim Chief Financial Officer |